Yifan Han
Secretary & Investor Relations Associate DirectorMs. Yifan Han is Secretary & Investor Relations Associate Director of IMPACT Therapeutics, Inc. Ms. Han joined the IMPACT Therapeutics, Inc. in June 2023. Ms. Han has extensive experience in auditing, mergers and acquisitions and investor relations within the healthcare and biopharmaceutical sectors. From September 2014 to April 2016, she began her career as an audit associate at Ernst & Young Hua Ming LLP. Later she served as a senior consultant in the M&A Transaction Group at PwC Consulting from April 2016 to June 2017. She subsequently worked as senior audit manager (M&A due diligence) at Horizon Healthcare Investment & Holding (Shanghai) Co., Ltd, a wholly owned subsidiary of Far East Horizon Limited (stock code: 3360), from June 2017 to May 2018. She worked as a senior finance manager at Genor Biopharma Co. Ltd., a subsidiary of JHBP (CY) HOLDINGS LIMITED (listed on the Stock Exchange, stock code: 6998) from May 2019 to October 2020. After that, she worked as a senior manager of investor relations at VISEN Pharmaceuticals Shanghai Co., Ltd., a subsidiary of VISEN Pharmaceuticals (listed on the Stock Exchange, stock code: 2561) from November 2020 to June 2023. Ms. Han obtained a bachelor’s degrees in business administration (entrepreneurship management) and a bachelor’s degree in German language and literature from Zhejiang University in the PRC and a master’s degree in German language and literature from Nanjing University in the PRC.
Positions
- Company NameIMPACT Therapeutics, IncStock Code07630PositionSecretary & Investor Relations Associate Director
